CDC/ACIP [to 24 Aug 2019]

CDC/ACIP [to 24 Aug 2019]
Latest News
Thursday, August 22, 2019
An Estimated 92% of Cancers Caused by HPV Could be Prevented by Vaccine
During 2012-2016, an average of 43,999 HPV-associated cancers were reported each year, according to a new study published today in CDC’s  Morbidity and Mortality Weekly Report (MMWR). Among the estimated 34,800 cancers probably caused by HPV, 92 percent are attributable to the HPV types that are included in the HPV vaccine and could be prevented if HPV vaccine recommendations were followed, according to the report.

MMWR News Synopsis for Friday, August 23, 2019
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2018
2018 data show that adolescent human papillomavirus (HPV) vaccination rates increased slightly, but more work needs to be done to protect more people against HPV-associated cancers. A new report from the CDC shows little progress toward increasing HPV vaccination rates among teenagers 13-17 years old. HPV vaccination rates increased slightly for boys, but there was no increase in rates among girls, highlighting the need for continued efforts to ensure all boys and girls are vaccinated on time. The percentage of teen boys and girls who received all recommended doses of the HPV vaccine increased from 49% to 51%. The increase in HPV vaccination rates was due to increases in boys only. The percentage of boys who received all recommended doses increased by 4 percentage points compared to 0.6 percentage points among girls. HPV vaccination rates were higher among teens whose parents reported receiving a recommendation from their child’s healthcare professional.

Human Papillomavirus–Attributable Cancers — United States, 2012–2016
Human papillomavirus (HPV) is a common virus that can lead to certain types of cancer later in life. The current HPV vaccine could prevent 92% percent of cancers attributable to HPV. A new CDC study found that there were 43,999 HPV-associated cancers (cancers in organ sites where HPV often causes cancer) from 2012 through 2016. CDC researchers estimated the annual number of cancers that can potentially be prevented by the current vaccine for the nation and for each state. The current HPV vaccine protects against 92% or 32,100 of the 34,8000 cancers thought to be caused by HPV from 2012 through 2016. In addition to HPV vaccination, cervical cancer screening is routinely recommended for women ages 21-65 regardless of HPV vaccination status.

Progress Toward Poliomyelitis Eradication — Afghanistan, January 2018–May 2019
To achieve polio eradication in Afghanistan, the vaccination program needs to reach approximately 10 million children, the majority of whom are currently not receiving oral poliovirus vaccine through house-to-house polio campaigns. This could be achieved by regaining access to communities and building community trust. A new report describes the progress toward polio eradication in Afghanistan during January 2018-May 2019. Afghanistan and Pakistan are the only two countries with reported cases of wild poliovirus type 1 (WPV1) since 2016. The number of WPV1 cases in Afghanistan has been increasing yearly since 2017. While circulation has remained confined to the Southern and Eastern regions of the country, the geographic range of WPV1 in Southern districts increased in 2019. A nationwide ban on house-to-house campaigns by antigovernment groups that has been in effect since April 2019 has left millions of children unvaccinated. To achieve polio eradication, the program needs to regain access to house-to-house campaigns and increase community demand for polio vaccine.

Recommendations and Reports:
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–2020 Influenza Season
This issue of MMWR Recommendations and Reports summarizes the latest data on influenza vaccination and lays out CDC and the Advisory Committee on Immunization Practices (ACIP) recommendations related to influenza vaccination. CDC recommends that everyone age 6 months and older should get a flu vaccine every year, with rare exceptions. There are many different types of flu vaccines available for different age groups and health indications. CDC does not recommend one flu vaccine over another. The most important thing is for all people 6 months and older to get a flu vaccination every year. If you have questions about which vaccine is best for you, talk to your doctor or other health care professional.

MMWR News Synopsis for Friday, August 16, 2019
Updated Recommendations of the Advisory Committee on Immunization Practices for Human Papillomavirus Vaccination of Adults
CDC recommends vaccination against human papillomavirus (HPV) at age 11 to 12 years, and now also recommends catch-up vaccination through age 26 years for all genders. Although CDC does not recommend catch-up vaccination for all adults ages 27 through 45 years, some people in this age range who are at risk for new HPV infection might benefit from vaccination. HPV vaccine prevents new HPV infections that can cause cancers and other health problems. Because vaccination provides the most benefit when given before exposure to any HPV, it is recommended for all 11- to 12-year-olds. Catch-up recommendations apply to people not vaccinated as preteens. This report updates CDC recommendations for adults in the United States.I It harmonizes the catch-up age through age 26 years for all genders and adds guidance about HPV vaccination for adults ages 27 through 45 years who are at risk for new HPV infection and might benefit from vaccination. Although 9-valent HPV vaccine is licensed for use through age 45 years, CDC does not recommend it for all such adults, and clinicians need not discuss HPV vaccination with all adults over the age of 26 years because most people in this age range are unlikely to benefit from vaccination.